Luye Pharma USA continues to advance clinical research and development through a pipeline of innovative therapies for CNS disorders.
ERZOFRI® (paliperidone palmitate)
is Luye’s first commercialized product in the US.
Get to Know ERZOFRI®
ERZOFRI® carries a BOXED WARNING:
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. ERZOFRI® is not approved for use in patients with dementia-related psychosis.